Effects of intravenous lidocaine in the enhanced recovery after surgery of hysteroscopic surgery under general anesthesia

Effects of intravenous lidocaine in the enhanced recovery after surgery of hysteroscopic surgery under general anesthesia: a single-center, randomized, parallel-controlled, and optimal clinical trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024201

Enrollment

Unknown

Registered

2019-06-30

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia in patients undergoing hysteroscopic surgery

Interventions

1:intravenous lidocanie

2:intravenous normal saline

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-II; 2. female patients,aged > 18 and < 65 years; 3. undergoing elective hysteroscopic surgery.

Exclusion criteria

Exclusion criteria: 1. Allergic to lidocaine; 2. Liver insufficiency; 3. Kidney failure; 4. Epilepsy; 5. Severe arrhythmia, hypertension and heart disease; 6. Regularly took analgesics or had taken opioids within 1 wk of surgery; 7. The operation lasts more than 30 minutes; 8. Intrauterine balloon placement under hysteroscopy.

Design outcomes

Primary

Measure	Time frame
propofol requirements;	—

Secondary

Measure	Time frame
mean arterial pressure;	—

Countries

China

Contacts

Public ContactYuantao Li

Shenzhen Maternity and Child Healthcare Hospital

sylyt6788@sina.com+86 15013857589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026